Logo image of RFL

RAFAEL HOLDINGS INC-CLASS B (RFL) Stock Price, Quote, News and Overview

NYSE:RFL - New York Stock Exchange, Inc. - US75062E1064 - Common Stock - Currency: USD

2.11  +0.03 (+1.44%)

RFL Quote, Performance and Key Statistics

RAFAEL HOLDINGS INC-CLASS B

NYSE:RFL (2/11/2025, 8:04:00 PM)

2.11

+0.03 (+1.44%)

Sector
GICS SectorReal Estate
GICS IndustryReal Estate Management & Development
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS SubIndustryReal Estate Operating Companies
Statistics
52 Week High2.5
52 Week Low1.29
Market Cap52.05M
Shares24.67M
Float18.99M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-11 2025-03-11
IPO03-12 2018-03-12


RFL short term performance overview.The bars show the price performance of RFL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

RFL long term performance overview.The bars show the price performance of RFL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20 -30

The current stock price of RFL is 2.11 USD. In the past month the price increased by 11.64%. In the past year, price increased by 12.83%.

RAFAEL HOLDINGS INC-CLASS B / RFL Daily stock chart

RFL Latest News and Analysis

News Image
2 months ago - Rafael Holdings, Inc.

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

Upon completion of our proposed merger with Cyclo Therapeutics the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol® Cycloâ„¢

News Image
2 months ago - Rafael Holdings, Inc.

Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

Upon completion of our proposed merger with Cyclo Therapeutics the Company intends to focus its efforts on Cyclo’s lead clinical program Trappsol® Cycloâ„¢...

News Image
3 months ago - Rafael Holdings, Inc.

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

Our proposed merger with Cyclo Therapeutics advances our strategy to invest in, develop and commercialize clinical stage assets which address areas of high unmet medical need

News Image
3 months ago - Rafael Holdings, Inc.

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

Our proposed merger with Cyclo Therapeutics advances our strategy to invest in, develop and commercialize clinical stage assets which address areas of high...

RFL Competitors/Peers

The largest stocks on the US markets in the "Real Estate Operating Companies" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LB LANDBRIDGE CO LLC-A N/A 5.62B
VTMX CORP INMOBILIARIA VESTA-ADR 4.86 2.28B
KW KENNEDY-WILSON HOLDINGS INC N/A 1.23B
IRS IRSA -SP ADR N/A 935.05M
MRNO MURANO GLOBAL INVESTMENTS PL N/A 856.58M
FRPH FRP HOLDINGS INC 57.31 599.83M
SEG SEAPORT ENTERTAINMENT GROUP N/A 323.34M
LPA LOGISTIC PROPERTIES OF THE A N/A 301.46M
OZ BELPOINTE PREP LLC N/A 239.96M
TCI TRANSCONTINENTAL REALTY INV 73.11 233.71M
ARL AMERICAN REALTY INVESTORS IN N/A 217.86M
SRG SERITAGE GROWTH PROP- A N/A 199.20M

About RFL

Company Profile

RFL logo image Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. Its segments include Healthcare, Infusion Technology and Real Estate. The Healthcare segment holds interest in LipoMedix Pharmaceuticals Ltd. (LipoMedix), Barer Institute Inc. (Barer), Cornerstone Pharmaceuticals, Inc. (Cornerstone) and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which is comprised of a portion of a commercial building in Israel. The Infusion Technology segment holds interest in Day Three Labs, Inc. LipoMedix is a clinical-stage pharmaceutical company. Rafael Medical Devices, LLC, an orthopedic-focused medical device company. Cornerstone Pharmaceuticals, Inc. is a cancer metabolism-based therapeutics company. Cyclo Therapeutics Inc. develops Trappsol Cyclo, which is being evaluated in clinical trials for the treatment of Niemann-Pick Disease Type C1 (NPC).

Company Info

RAFAEL HOLDINGS INC-CLASS B

520 Broad Street

Newark NEW JERSEY 07102 US

CEO: Ameet Mallik

Employees: 13

Company Website: https://rafaelholdings.com

Investor Relations: https://rafaelholdings.irpass.com/

Phone: 12126581450

RFL FAQ

What is the stock price of RFL?

The current stock price of RFL is 2.11 USD.


What is the symbol for RAFAEL HOLDINGS INC-CLASS B stock?

The exchange symbol of RAFAEL HOLDINGS INC-CLASS B is RFL and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is RFL stock listed?

RFL stock is listed on the New York Stock Exchange, Inc. exchange.


Is RFL a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for RFL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of RFL.


Does RFL stock pay dividends?

RFL does not pay a dividend.


When does RFL stock report earnings?

RFL will report earnings on 2025-03-11.


What is the Price/Earnings (PE) ratio of RFL?

RFL does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.45).


What is the Short Interest ratio of RFL stock?

The outstanding short interest for RFL is 0.54% of its float.


RFL Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to RFL. When comparing the yearly performance of all stocks, RFL is one of the better performing stocks in the market, outperforming 77.74% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

RFL Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RFL. RFL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

RFL Financial Highlights

Over the last trailing twelve months RFL reported a non-GAAP Earnings per Share(EPS) of -1.45. The EPS increased by -1716.77% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -35.54%
ROE -41.87%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%-473.6%
Sales Q2Q%135.71%
EPS 1Y (TTM)-1716.77%
Revenue 1Y (TTM)127.5%

RFL Ownership and Analysts


Ownership
Inst Owners10.77%
Ins Owners7.27%
Short Float %0.54%
Short Ratio2.79
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A